Direct Oral Anticoagulant market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Direct Oral Anticoagulant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Apixaban Dabigatran Rivaroxaban Edoxaban Segment by Application Hospitals Pharmacies Drug Stores Online Pharmacies By Company Bristol-Meyers Squibb Co Pfizer Inc. Boehringer Ingelheim Pharmaceuticals, Inc Janssen Pharmaceuticals, Inc. Bayer AG Teva Pharmaceutical Industries Ltd Pab Organics Private Limited Daiichi Sankyo Company, Limited By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E
1 Study Coverage 1.1 Direct Oral Anticoagulant Product Introduction 1.2 Market by Type 1.2.1 Global Direct Oral Anticoagulant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Apixaban 1.2.3 Dabigatran 1.2.4 Rivaroxaban 1.2.5 Edoxaban 1.3 Market by Application 1.3.1 Global Direct Oral Anticoagulant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals Pharmacies 1.3.3 Drug Stores 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Direct Oral Anticoagulant Sales Estimates and Forecasts 2017-2028 2.2 Global Direct Oral Anticoagulant Revenue Estimates and Forecasts 2017-2028 2.3 Global Direct Oral Anticoagulant Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Direct Oral Anticoagulant Sales by Region 2.4.1 Global Direct Oral Anticoagulant Sales by Region (2017-2022) 2.4.2 Global Sales Direct Oral Anticoagulant by Region (2023-2028) 2.5 Global Direct Oral Anticoagulant Revenue by Region 2.5.1 Global Direct Oral Anticoagulant Revenue by Region (2017-2022) 2.5.2 Global Direct Oral Anticoagulant Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Direct Oral Anticoagulant Sales by Manufacturers 3.1.1 Global Top Direct Oral Anticoagulant Manufacturers by Sales (2017-2022) 3.1.2 Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Direct Oral Anticoagulant in 2021 3.2 Global Direct Oral Anticoagulant Revenue by Manufacturers 3.2.1 Global Direct Oral Anticoagulant Revenue by Manufacturers (2017-2022) 3.2.2 Global Direct Oral Anticoagulant Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Direct Oral Anticoagulant Revenue in 2021 3.3 Global Direct Oral Anticoagulant Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Direct Oral Anticoagulant Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Direct Oral Anticoagulant Sales by Type 4.1.1 Global Direct Oral Anticoagulant Historical Sales by Type (2017-2022) 4.1.2 Global Direct Oral Anticoagulant Forecasted Sales by Type (2023-2028) 4.1.3 Global Direct Oral Anticoagulant Sales Market Share by Type (2017-2028) 4.2 Global Direct Oral Anticoagulant Revenue by Type 4.2.1 Global Direct Oral Anticoagulant Historical Revenue by Type (2017-2022) 4.2.2 Global Direct Oral Anticoagulant Forecasted Revenue by Type (2023-2028) 4.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028) 4.3 Global Direct Oral Anticoagulant Price by Type 4.3.1 Global Direct Oral Anticoagulant Price by Type (2017-2022) 4.3.2 Global Direct Oral Anticoagulant Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Direct Oral Anticoagulant Sales by Application 5.1.1 Global Direct Oral Anticoagulant Historical Sales by Application (2017-2022) 5.1.2 Global Direct Oral Anticoagulant Forecasted Sales by Application (2023-2028) 5.1.3 Global Direct Oral Anticoagulant Sales Market Share by Application (2017-2028) 5.2 Global Direct Oral Anticoagulant Revenue by Application 5.2.1 Global Direct Oral Anticoagulant Historical Revenue by Application (2017-2022) 5.2.2 Global Direct Oral Anticoagulant Forecasted Revenue by Application (2023-2028) 5.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028) 5.3 Global Direct Oral Anticoagulant Price by Application 5.3.1 Global Direct Oral Anticoagulant Price by Application (2017-2022) 5.3.2 Global Direct Oral Anticoagulant Price Forecast by Application (2023-2028) 6 North America 6.1 North America Direct Oral Anticoagulant Market Size by Type 6.1.1 North America Direct Oral Anticoagulant Sales by Type (2017-2028) 6.1.2 North America Direct Oral Anticoagulant Revenue by Type (2017-2028) 6.2 North America Direct Oral Anticoagulant Market Size by Application 6.2.1 North America Direct Oral Anticoagulant Sales by Application (2017-2028) 6.2.2 North America Direct Oral Anticoagulant Revenue by Application (2017-2028) 6.3 North America Direct Oral Anticoagulant Market Size by Country 6.3.1 North America Direct Oral Anticoagulant Sales by Country (2017-2028) 6.3.2 North America Direct Oral Anticoagulant Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Direct Oral Anticoagulant Market Size by Type 7.1.1 Europe Direct Oral Anticoagulant Sales by Type (2017-2028) 7.1.2 Europe Direct Oral Anticoagulant Revenue by Type (2017-2028) 7.2 Europe Direct Oral Anticoagulant Market Size by Application 7.2.1 Europe Direct Oral Anticoagulant Sales by Application (2017-2028) 7.2.2 Europe Direct Oral Anticoagulant Revenue by Application (2017-2028) 7.3 Europe Direct Oral Anticoagulant Market Size by Country 7.3.1 Europe Direct Oral Anticoagulant Sales by Country (2017-2028) 7.3.2 Europe Direct Oral Anticoagulant Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Direct Oral Anticoagulant Market Size by Type 8.1.1 Asia Pacific Direct Oral Anticoagulant Sales by Type (2017-2028) 8.1.2 Asia Pacific Direct Oral Anticoagulant Revenue by Type (2017-2028) 8.2 Asia Pacific Direct Oral Anticoagulant Market Size by Application 8.2.1 Asia Pacific Direct Oral Anticoagulant Sales by Application (2017-2028) 8.2.2 Asia Pacific Direct Oral Anticoagulant Revenue by Application (2017-2028) 8.3 Asia Pacific Direct Oral Anticoagulant Market Size by Region 8.3.1 Asia Pacific Direct Oral Anticoagulant Sales by Region (2017-2028) 8.3.2 Asia Pacific Direct Oral Anticoagulant Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Direct Oral Anticoagulant Market Size by Type 9.1.1 Latin America Direct Oral Anticoagulant Sales by Type (2017-2028) 9.1.2 Latin America Direct Oral Anticoagulant Revenue by Type (2017-2028) 9.2 Latin America Direct Oral Anticoagulant Market Size by Application 9.2.1 Latin America Direct Oral Anticoagulant Sales by Application (2017-2028) 9.2.2 Latin America Direct Oral Anticoagulant Revenue by Application (2017-2028) 9.3 Latin America Direct Oral Anticoagulant Market Size by Country 9.3.1 Latin America Direct Oral Anticoagulant Sales by Country (2017-2028) 9.3.2 Latin America Direct Oral Anticoagulant Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Direct Oral Anticoagulant Market Size by Type 10.1.1 Middle East and Africa Direct Oral Anticoagulant Sales by Type (2017-2028) 10.1.2 Middle East and Africa Direct Oral Anticoagulant Revenue by Type (2017-2028) 10.2 Middle East and Africa Direct Oral Anticoagulant Market Size by Application 10.2.1 Middle East and Africa Direct Oral Anticoagulant Sales by Application (2017-2028) 10.2.2 Middle East and Africa Direct Oral Anticoagulant Revenue by Application (2017-2028) 10.3 Middle East and Africa Direct Oral Anticoagulant Market Size by Country 10.3.1 Middle East and Africa Direct Oral Anticoagulant Sales by Country (2017-2028) 10.3.2 Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Bristol-Meyers Squibb Co 11.1.1 Bristol-Meyers Squibb Co Corporation Information 11.1.2 Bristol-Meyers Squibb Co Overview 11.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Bristol-Meyers Squibb Co Recent Developments 11.2 Pfizer Inc. 11.2.1 Pfizer Inc. Corporation Information 11.2.2 Pfizer Inc. Overview 11.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Pfizer Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Pfizer Inc. Recent Developments 11.3 Boehringer Ingelheim Pharmaceuticals, Inc 11.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information 11.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Overview 11.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments 11.4 Janssen Pharmaceuticals, Inc. 11.4.1 Janssen Pharmaceuticals, Inc. Corporation Information 11.4.2 Janssen Pharmaceuticals, Inc. Overview 11.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Janssen Pharmaceuticals, Inc. Recent Developments 11.5 Bayer AG 11.5.1 Bayer AG Corporation Information 11.5.2 Bayer AG Overview 11.5.3 Bayer AG Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Bayer AG Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Bayer AG Recent Developments 11.6 Teva Pharmaceutical Industries Ltd 11.6.1 Teva Pharmaceutical Industries Ltd Corporation Information 11.6.2 Teva Pharmaceutical Industries Ltd Overview 11.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Teva Pharmaceutical Industries Ltd Recent Developments 11.7 Pab Organics Private Limited 11.7.1 Pab Organics Private Limited Corporation Information 11.7.2 Pab Organics Private Limited Overview 11.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Pab Organics Private Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Pab Organics Private Limited Recent Developments 11.8 Daiichi Sankyo Company, Limited 11.8.1 Daiichi Sankyo Company, Limited Corporation Information 11.8.2 Daiichi Sankyo Company, Limited Overview 11.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Daiichi Sankyo Company, Limited Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Direct Oral Anticoagulant Industry Chain Analysis 12.2 Direct Oral Anticoagulant Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Direct Oral Anticoagulant Production Mode & Process 12.4 Direct Oral Anticoagulant Sales and Marketing 12.4.1 Direct Oral Anticoagulant Sales Channels 12.4.2 Direct Oral Anticoagulant Distributors 12.5 Direct Oral Anticoagulant Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Direct Oral Anticoagulant Industry Trends 13.2 Direct Oral Anticoagulant Market Drivers 13.3 Direct Oral Anticoagulant Market Challenges 13.4 Direct Oral Anticoagulant Market Restraints 14 Key Findings in The Global Direct Oral Anticoagulant Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
List of Tables Table 1. Global Direct Oral Anticoagulant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Apixaban Table 3. Major Manufacturers of Dabigatran Table 4. Major Manufacturers of Rivaroxaban Table 5. Major Manufacturers of Edoxaban Table 6. Global Direct Oral Anticoagulant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Direct Oral Anticoagulant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Direct Oral Anticoagulant Sales by Region (2017-2022) & (MT) Table 9. Global Direct Oral Anticoagulant Sales Market Share by Region (2017-2022) Table 10. Global Direct Oral Anticoagulant Sales by Region (2023-2028) & (MT) Table 11. Global Direct Oral Anticoagulant Sales Market Share by Region (2023-2028) Table 12. Global Direct Oral Anticoagulant Revenue by Region (2017-2022) & (US$ Million) Table 13. Global Direct Oral Anticoagulant Revenue Market Share by Region (2017-2022) Table 14. Global Direct Oral Anticoagulant Revenue by Region (2023-2028) & (US$ Million) Table 15. Global Direct Oral Anticoagulant Revenue Market Share by Region (2023-2028) Table 16. Global Direct Oral Anticoagulant Sales by Manufacturers (2017-2022) & (MT) Table 17. Global Direct Oral Anticoagulant Sales Share by Manufacturers (2017-2022) Table 18. Global Direct Oral Anticoagulant Revenue by Manufacturers (2017-2022) & (US$ Million) Table 19. Global Direct Oral Anticoagulant Revenue Share by Manufacturers (2017-2022) Table 20. Direct Oral Anticoagulant Price by Manufacturers (2017-2022) &(USD/Kg) Table 21. Global Direct Oral Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Direct Oral Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct Oral Anticoagulant as of 2021) Table 23. Direct Oral Anticoagulant Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Direct Oral Anticoagulant Product Offered Table 25. Date of Manufacturers Enter into Direct Oral Anticoagulant Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT) Table 28. Global Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT) Table 29. Global Direct Oral Anticoagulant Sales Share by Type (2017-2022) Table 30. Global Direct Oral Anticoagulant Sales Share by Type (2023-2028) Table 31. Global Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million) Table 32. Global Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million) Table 33. Global Direct Oral Anticoagulant Revenue Share by Type (2017-2022) Table 34. Global Direct Oral Anticoagulant Revenue Share by Type (2023-2028) Table 35. Direct Oral Anticoagulant Price by Type (2017-2022) & (USD/Kg) Table 36. Global Direct Oral Anticoagulant Price Forecast by Type (2023-2028) & (USD/Kg) Table 37. Global Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT) Table 38. Global Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT) Table 39. Global Direct Oral Anticoagulant Sales Share by Application (2017-2022) Table 40. Global Direct Oral Anticoagulant Sales Share by Application (2023-2028) Table 41. Global Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million) Table 42. Global Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million) Table 43. Global Direct Oral Anticoagulant Revenue Share by Application (2017-2022) Table 44. Global Direct Oral Anticoagulant Revenue Share by Application (2023-2028) Table 45. Direct Oral Anticoagulant Price by Application (2017-2022) & (USD/Kg) Table 46. Global Direct Oral Anticoagulant Price Forecast by Application (2023-2028) & (USD/Kg) Table 47. North America Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT) Table 48. North America Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT) Table 49. North America Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million) Table 50. North America Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million) Table 51. North America Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT) Table 52. North America Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT) Table 53. North America Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million) Table 54. North America Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million) Table 55. North America Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT) Table 56. North America Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT) Table 57. North America Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million) Table 58. North America Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million) Table 59. Europe Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT) Table 60. Europe Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT) Table 61. Europe Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million) Table 62. Europe Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million) Table 63. Europe Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT) Table 64. Europe Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT) Table 65. Europe Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million) Table 66. Europe Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million) Table 67. Europe Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT) Table 68. Europe Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT) Table 69. Europe Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million) Table 70. Europe Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million) Table 71. Asia Pacific Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT) Table 72. Asia Pacific Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT) Table 73. Asia Pacific Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million) Table 74. Asia Pacific Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million) Table 75. Asia Pacific Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT) Table 76. Asia Pacific Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT) Table 77. Asia Pacific Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million) Table 78. Asia Pacific Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million) Table 79. Asia Pacific Direct Oral Anticoagulant Sales by Region (2017-2022) & (MT) Table 80. Asia Pacific Direct Oral Anticoagulant Sales by Region (2023-2028) & (MT) Table 81. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2017-2022) & (US$ Million) Table 82. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2023-2028) & (US$ Million) Table 83. Latin America Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT) Table 84. Latin America Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT) Table 85. Latin America Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million) Table 86. Latin America Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million) Table 87. Latin America Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT) Table 88. Latin America Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT) Table 89. Latin America Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million) Table 90. Latin America Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million) Table 91. Latin America Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT) Table 92. Latin America Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT) Table 93. Latin America Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million) Table 94. Latin America Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million) Table 95. Middle East and Africa Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT) Table 96. Middle East and Africa Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT) Table 97. Middle East and Africa Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million) Table 98. Middle East and Africa Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million) Table 99. Middle East and Africa Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT) Table 100. Middle East and Africa Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT) Table 101. Middle East and Africa Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million) Table 102. Middle East and Africa Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million) Table 103. Middle East and Africa Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT) Table 104. Middle East and Africa Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT) Table 105. Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million) Table 106. Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million) Table 107. Bristol-Meyers Squibb Co Corporation Information Table 108. Bristol-Meyers Squibb Co Description and Major Businesses Table 109. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 110. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 111. Bristol-Meyers Squibb Co Recent Developments Table 112. Pfizer Inc. Corporation Information Table 113. Pfizer Inc. Description and Major Businesses Table 114. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 115. Pfizer Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Pfizer Inc. Recent Developments Table 117. Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information Table 118. Boehringer Ingelheim Pharmaceuticals, Inc Description and Major Businesses Table 119. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 120. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments Table 122. Janssen Pharmaceuticals, Inc. Corporation Information Table 123. Janssen Pharmaceuticals, Inc. Description and Major Businesses Table 124. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 125. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 126. Janssen Pharmaceuticals, Inc. Recent Developments Table 127. Bayer AG Corporation Information Table 128. Bayer AG Description and Major Businesses Table 129. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 130. Bayer AG Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 131. Bayer AG Recent Developments Table 132. Teva Pharmaceutical Industries Ltd Corporation Information Table 133. Teva Pharmaceutical Industries Ltd Description and Major Businesses Table 134. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 135. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 136. Teva Pharmaceutical Industries Ltd Recent Developments Table 137. Pab Organics Private Limited Corporation Information Table 138. Pab Organics Private Limited Description and Major Businesses Table 139. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 140. Pab Organics Private Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 141. Pab Organics Private Limited Recent Developments Table 142. Daiichi Sankyo Company, Limited Corporation Information Table 143. Daiichi Sankyo Company, Limited Description and Major Businesses Table 144. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 145. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications Table 146. Daiichi Sankyo Company, Limited Recent Developments Table 147. Key Raw Materials Lists Table 148. Raw Materials Key Suppliers Lists Table 149. Direct Oral Anticoagulant Distributors List Table 150. Direct Oral Anticoagulant Customers List Table 151. Direct Oral Anticoagulant Market Trends Table 152. Direct Oral Anticoagulant Market Drivers Table 153. Direct Oral Anticoagulant Market Challenges Table 154. Direct Oral Anticoagulant Market Restraints Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Direct Oral Anticoagulant Product Picture Figure 3. Global Direct Oral Anticoagulant Market Share by Type in 2021 & 2028 Figure 3. Apixaban Product Picture Figure 4. Dabigatran Product Picture Figure 5. Rivaroxaban Product Picture Figure 6. Edoxaban Product Picture Figure 7. Global Direct Oral Anticoagulant Market Share by Application in 2021 & 2028 Figure 8. Hospitals Pharmacies Figure 9. Drug Stores Figure 10. Online Pharmacies Figure 11. Direct Oral Anticoagulant Report Years Considered Figure 12. Global Direct Oral Anticoagulant Sales 2017-2028 (MT) Figure 13. Global Direct Oral Anticoagulant Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Direct Oral Anticoagulant Revenue 2017-2028 (US$ Million) Figure 15. Global Direct Oral Anticoagulant Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 16. Global Direct Oral Anticoagulant Sales Market Share by Region (2017-2022) Figure 17. Global Direct Oral Anticoagulant Sales Market Share by Region (2023-2028) Figure 18. North America Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT) Figure 19. North America Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million) Figure 20. Europe Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT) Figure 21. Europe Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million) Figure 22. Asia-Pacific Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT) Figure 23. Asia-Pacific Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million) Figure 24. Latin America Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT) Figure 25. Latin America Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million) Figure 26. Middle East & Africa Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT) Figure 27. Middle East & Africa Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million) Figure 28. The Direct Oral Anticoagulant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 29. The Top 5 and 10 Largest Manufacturers of Direct Oral Anticoagulant in the World: Market Share by Direct Oral Anticoagulant Revenue in 2021 Figure 30. Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 31. Global Direct Oral Anticoagulant Sales Market Share by Type (2017-2028) Figure 32. Global Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028) Figure 33. Global Direct Oral Anticoagulant Sales Market Share by Application (2017-2028) Figure 34. Global Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028) Figure 35. North America Direct Oral Anticoagulant Sales Market Share by Type (2017-2028) Figure 36. North America Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028) Figure 37. North America Direct Oral Anticoagulant Sales Market Share by Application (2017-2028) Figure 38. North America Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028) Figure 39. North America Direct Oral Anticoagulant Sales Share by Country (2017-2028) Figure 40. North America Direct Oral Anticoagulant Revenue Share by Country (2017-2028) Figure 41. U.S. Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 42. Canada Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 43. Europe Direct Oral Anticoagulant Sales Market Share by Type (2017-2028) Figure 44. Europe Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028) Figure 45. Europe Direct Oral Anticoagulant Sales Market Share by Application (2017-2028) Figure 46. Europe Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028) Figure 47. Europe Direct Oral Anticoagulant Sales Share by Country (2017-2028) Figure 48. Europe Direct Oral Anticoagulant Revenue Share by Country (2017-2028) Figure 49. Germany Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 50. France Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 51. U.K. Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 52. Italy Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 53. Russia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 54. Asia Pacific Direct Oral Anticoagulant Sales Market Share by Type (2017-2028) Figure 55. Asia Pacific Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028) Figure 56. Asia Pacific Direct Oral Anticoagulant Sales Market Share by Application (2017-2028) Figure 57. Asia Pacific Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028) Figure 58. Asia Pacific Direct Oral Anticoagulant Sales Share by Region (2017-2028) Figure 59. Asia Pacific Direct Oral Anticoagulant Revenue Share by Region (2017-2028) Figure 60. China Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 61. Japan Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 62. South Korea Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 63. India Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 64. Australia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 65. Taiwan Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 66. Indonesia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 67. Thailand Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 68. Malaysia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 69. Philippines Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 70. Latin America Direct Oral Anticoagulant Sales Market Share by Type (2017-2028) Figure 71. Latin America Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028) Figure 72. Latin America Direct Oral Anticoagulant Sales Market Share by Application (2017-2028) Figure 73. Latin America Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028) Figure 74. Latin America Direct Oral Anticoagulant Sales Share by Country (2017-2028) Figure 75. Latin America Direct Oral Anticoagulant Revenue Share by Country (2017-2028) Figure 76. Mexico Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 77. Brazil Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 78. Argentina Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 79. Middle East and Africa Direct Oral Anticoagulant Sales Market Share by Type (2017-2028) Figure 80. Middle East and Africa Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028) Figure 81. Middle East and Africa Direct Oral Anticoagulant Sales Market Share by Application (2017-2028) Figure 82. Middle East and Africa Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028) Figure 83. Middle East and Africa Direct Oral Anticoagulant Sales Share by Country (2017-2028) Figure 84. Middle East and Africa Direct Oral Anticoagulant Revenue Share by Country (2017-2028) Figure 85. Turkey Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 86. Saudi Arabia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 87. U.A.E Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million) Figure 88. Direct Oral Anticoagulant Value Chain Figure 89. Direct Oral Anticoagulant Production Process Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed